Stroma AReactive Invasion Front Areas (SARIFA) proves prognostic relevance in gastric carcinoma and is based on a tumor-adipocyte interaction indicating an altered immune response.

Gastric Cancer · 2024 · PMC10761465 · PMID 37874427

Europe PMC DOI

hedged sentence

0.1790

closest p · 3.6× alpha

0.1790

boldest claim

The sentences

showed a trendp = 0.179not close (p > 0.1)

Patients with SARIFA-negative tumors showed a trend toward better progression-free survival (HR 1.357, 95% CI 0.869–2.118, p = 0.179) and disease-free survival (HR 1.648, 95% CI 0.802–3.383, p = 0.174) (Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.